-
Thematic Analysis
NewRNA-Based Drugs and the Impact of COVID-19
This report investigates the past, current and future landscape of RNA-Based drugs, and how the success of the COVID-19 vaccines may have impacted this. High level analysis of the key trends and movements within the pharmaceutical industry in reference to RNA technology is provided, allowing you to identify and discern the key points within this area.
-
Sector Analysis
COVID-19 Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
COVID-19 tests Market Report Overview The COVID-19 tests market size was valued at $23.97 billion in 2023. Severe Acute Respiratory Syndrome Coronavirus, SARS‐CoV‐2, a novel coronavirus from the same family as SARS‐CoV and Middle East respiratory syndrome coronavirus, has spread worldwide leading the World Health Organization (WHO) to declare a pandemic. The disease caused by SARS‐CoV‐2, coronavirus disease 2019 (COVID‐19), presents flu‐like symptoms that can become serious in high‐risk individuals, is a rapidly evolving situation across the globe, and has...
-
Product Insights
COVID-19 Nucleic Acid Amplification Tests (NAATs) Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies
COVID-19 Nucleic Acid Amplification Tests (NAATs) Pipeline Market Report Overview Nucleic Acid Amplification Tests (NAAT) involve the amplification of specific nucleic acid sequences of the SARS-CoV-2 virus by targeting specific nucleic acid sequences. NAAT exhibits better sensitivity in comparison to other antigen identification methods. The COVID-19 NAATs pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cellular Immunotherapy 2 For Oncology And Coronavirus Disease 2019 (COVID-19) in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cellular Immunotherapy 2 For Oncology And Coronavirus Disease 2019 (COVID-19) in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cellular Immunotherapy 2...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Coronavirus Disease 2019 (Covid-19) Vaccine in Middle East Respiratory Syndrome (MERS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Coronavirus Disease 2019 (Covid-19) Vaccine in Middle East Respiratory Syndrome (MERS) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Coronavirus Disease 2019 (Covid-19) Vaccine in...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cell Therapy For Coronavirus Disease 2019 (COVID-19), Alopecia Areata And Type 1 Diabetes in Alopecia Areata
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cell Therapy For Coronavirus Disease 2019 (COVID-19), Alopecia Areata And Type 1 Diabetes in Alopecia Areata report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Oncolytic Virus For Human Papillomavirus Associated Cancer, Human Papillomavirus Infections And Coronavirus Disease 2019 (COVID-19) in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Oncolytic Virus For Human Papillomavirus Associated Cancer, Human Papillomavirus Infections And Coronavirus Disease 2019 (COVID-19) in Cervical Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cell Therapy for Coronavirus Disease 2019 (COVID-19), Alopecia Areata and Type 1 Diabetes in Type 1 Diabetes (Juvenile Diabetes)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cell Therapy for Coronavirus Disease 2019 (COVID-19), Alopecia Areata and Type 1 Diabetes in Type 1 Diabetes (Juvenile Diabetes) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Oncolytic Virus For Human Papillomavirus Associated Cancer, Human Papillomavirus Infections And Coronavirus Disease 2019 (COVID-19) in Cervical Intraepithelial Neoplasia (CIN)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Oncolytic Virus For Human Papillomavirus Associated Cancer, Human Papillomavirus Infections And Coronavirus Disease 2019 (COVID-19) in Cervical Intraepithelial Neoplasia (CIN) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10...